Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
AO Kamphorst, RN Pillai, S Yang… - Proceedings of the …, 2017 - National Acad Sciences
Exhausted T cells in chronic infections and cancer have sustained expression of the
inhibitory receptor programmed cell death 1 (PD-1). Therapies that block the PD-1 pathway …
inhibitory receptor programmed cell death 1 (PD-1). Therapies that block the PD-1 pathway …
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
AO Kamphorst, RN Pillai, S Yang, TH Nasti… - Proceedings of the …, 2017 - cir.nii.ac.jp
抄録< jats: title> Significance</jats: title>< jats: p> Therapies that harness the immune
system have recently been approved for cancer treatment. Identification of biomarkers to …
system have recently been approved for cancer treatment. Identification of biomarkers to …
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients.
AO Kamphorst, RN Pillai, S Yang, TH Nasti… - Proceedings of the …, 2017 - europepmc.org
Exhausted T cells in chronic infections and cancer have sustained expression of the
inhibitory receptor programmed cell death 1 (PD-1). Therapies that block the PD-1 pathway …
inhibitory receptor programmed cell death 1 (PD-1). Therapies that block the PD-1 pathway …
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients
AO Kamphorst, RN Pillai, S Yang… - … of the National …, 2017 - ohiostate.elsevierpure.com
Exhausted T cells in chronic infections and cancer have sustained expression of the
inhibitory receptor programmed cell death 1 (PD-1). Therapies that block the PD-1 pathway …
inhibitory receptor programmed cell death 1 (PD-1). Therapies that block the PD-1 pathway …
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
AO Kamphorst, RN Pillai, S Yang, TH Nasti… - Proceedings of the …, 2017 - JSTOR
Exhausted T cells in chronic infections and cancer have sustained expression of the
inhibitory receptor programmed cell death 1 (PD-1). Therapies that block the PD-1 pathway …
inhibitory receptor programmed cell death 1 (PD-1). Therapies that block the PD-1 pathway …
[PDF][PDF] Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
AO Kamphorsta, RN Pillaib, S Yanga, TH Nastia… - PNAS, 2017 - academia.edu
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung
cancer patients Page 1 Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted …
cancer patients Page 1 Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted …
[HTML][HTML] Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
AO Kamphorst, RN Pillai, S Yang, TH Nasti… - Proceedings of the …, 2017 - ncbi.nlm.nih.gov
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung
cancer patients - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
cancer patients - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients
AO Kamphorst, RN Pillai, S Yang… - Proceedings of the …, 2017 - ui.adsabs.harvard.edu
Therapies that harness the immune system have recently been approved for cancer
treatment. Identification of biomarkers to monitor or predict patients' responses to …
treatment. Identification of biomarkers to monitor or predict patients' responses to …
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients
AO Kamphorst, RN Pillai, S Yang… - Proceedings of the …, 2017 - pubmed.ncbi.nlm.nih.gov
Exhausted T cells in chronic infections and cancer have sustained expression of the
inhibitory receptor programmed cell death 1 (PD-1). Therapies that block the PD-1 pathway …
inhibitory receptor programmed cell death 1 (PD-1). Therapies that block the PD-1 pathway …
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients.
AO Kamphorst, RN Pillai, S Yang, TH Nasti… - Proceedings of the …, 2017 - europepmc.org
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung
cancer patients. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …
cancer patients. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …